23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to their Genetic Information
News Jun 10, 2009
23andMe, Inc. and Palomar Pomerado Health (PPH) have announced that PPH will be offering the 23andMe Personal Genome Service for sale to San Diegans at its outpatient health centers.
As an innovator in preventive health care, PPH encourages its communities to understand their genetic information in order to make more informed decisions about their health. This partnership marks the first time that a healthcare organization has provided the Personal Genome Service to members of its community, and the first time that 23andMe has made the service available for purchase outside of its website.
PPH will be offering the Personal Genome Service for $399 at two of its expresscare retail health centers in Escondido and Rancho Penasquitos, as well as the Pomerado Outpatient Pavilion (POP) in Poway. PPH patients who purchase the service at those locations also will receive a live, 30-minute Personal Education Session with a PPH nurse practitioner who can help answer questions they may have about the process and provide a tour of the Personal Genome Service.
The 23andMe Personal Genome Service provides information about how markers in a person's genome affects his or her propensity for over 100 health conditions and inherited traits, including prostate cancer, Type 2 Diabetes, venous thromboembolism, and cystic fibrosis.
The service also provides users with information about their ancestry, allows them to compare their genome to those of family and friends who are also 23andMe participants, and contribute to the advancement of genetic research by participating in 23andMe research studies.
PPH has taken an active role in promoting preventive health care. Because genetics is a major factor in the development of health conditions and diseases, PPH believes that individualized genetic information can help members make more educated lifestyle and healthcare decisions, as well as helping physicians better understand their patients' health.
Dr. Jerry Kolins, MD, FACHE, Associate Chief Medical Quality Officer and Medical Director for PPH Laboratories, said, “PPH is in the business of helping our members lead healthier lives. Because genetics significantly impacts a person's risk for developing certain diseases, having access to genetic information can be useful for both patients and physicians in helping to prevent health problems down the road.”
23andMe believes that providing genetic information to patients through partnerships such as this will facilitate the future integration of genetic information into medical practice.
23andMe co-founder Linda Avey said, “As more genetic discoveries are made and the clinical impact of these correlations is more fully understood, physicians and patients will be better equipped to incorporate genetic information into health care and lifestyle decisions. PPH recognizes that providing their patients with their genetic information now is the first step on this path to more personalized health care and prevention.”
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare DiseasesNews
Researchers at the LSU Computational Systems Biology group have developed a sophisticated and systematic way to identify existing drugs that can be repositioned to treat a rare disease or condition.READ MORE